The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
Open accessAbstract
Glycosylation of the immunoglobulin G (IgG)-Fc tail is required for binding to Fc-gamma receptors (FcγRs) and complement-component C1q. A variety of IgG1-glycoforms is detected in human sera. Several groups have found global or antigen-specific skewing of IgG glycosylation, for example in autoimmune diseases, viral infections, and alloimmune reactions. The IgG glycoprofiles seem to correlate with disease outcome. Additionally, IgG-glycan composition contributes significantly to Ig-based therapies, as for example IVIg in autoimmune diseases and therapeutic antibodies for cancer treatment. The effect of the different glycan modifications, especially of fucosylation, has been studied before. However, the contribution of the 20 individual IgG glycoforms, in which the combined effect of all 4 modifications, to the IgG function has never been investigated. Here, we combined six glyco-engineering methods to generate all 20 major human IgG1-glycoforms and screened their functional capacity for FcγR and complement activity. Bisection had no effect on FcγR or C1q-binding, and sialylation had no- or little effect on FcγR binding. We confirmed that hypo-fucosylation of IgG1 increased binding to FcγRIIIa and FcγRIIIb by ~17-fold, but in addition we showed that this effect could be further increased to ~40-fold for FcγRIIIa upon simultaneous hypo-fucosylation and hyper-galactosylation, resulting in enhanced NK cell-mediated antibody-dependent cellular cytotoxicity. Moreover, elevated galactosylation and sialylation significantly increased (independent of fucosylation) C1q-binding, downstream complement deposition, and cytotoxicity. In conclusion, fucosylation and galactosylation are primary mediators of functional changes in IgG for FcγR- and complement-mediated effector functions, respectively, with galactose having an auxiliary role for FcγRIII-mediated functions. This knowledge could be used not only for glycan profiling of clinically important (antigen-specific) IgG but also to optimize therapeutic antibody applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cross-platform toolkit for mass spectrometry and proteomics
Chambers, M. C., Maclean, B., Burke, R., Amodei, D., Ruderman, D. L., Neumann, S., Gatto, L., Fischer, B., Pratt, B., Egertson, J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2377 · Cited by 4,093
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Weiner, L. M., Surana, R., & Wang, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2744 · Cited by 1,283
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
de Lau, W., Barker, N., Low, T. Y., Koo, B.-K., Li, V. S. W., Teunissen, H., Kujala, P., Haegebarth, A., Peters, P. J., van de Wetering, M., et al. (2011) · Nature · doi:10.1038/nature10337 · Cited by 1,272
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J. R., et al. (2014) · Science · doi:10.1126/science.1248943 · Cited by 796
Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786
Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Building better monoclonal antibody-based therapeutics
Weiner, G. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3930 · Cited by 712
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans
Aitman, T. J., Dong, R., Vyse, T. J., Norsworthy, P. J., Johnson, M. D., Smith, J., Mangion, J., Roberton-Lowe, C., Marshall, A. J., Petretto, E., et al. (2006) · Nature · doi:10.1038/nature04489 · Cited by 666
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
(2005) · Wiley eBooks · doi:10.1002/0470011815 · Cited by 407
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., et al. (2017) · Science · doi:10.1126/science.aai8128 · Cited by 369
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Ackerman, M. E., Crispin, M., Yu, X., Baruah, K., Boesch, A. W., Harvey, D. J., Dugast, A.-S., Heizen, E. L., Ercan, A., Choi, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65708 · Cited by 358
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Jefferis, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.007 · Cited by 330
Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
Rodenko, B., Toebes, M., Hadrup, S. R., van Esch, W. J. E., Molenaar, A. M., Schumacher, T. N. M., & Ovaa, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.121 · Cited by 319
Self-citationAffinity of human IgG subclasses to mouse Fc gamma receptors
Dekkers, G., Bentlage, A. E. H., Stegmann, T. C., Howie, H. L., Lissenberg-Thunnissen, S., Zimring, J., Rispens, T., & Vidarsson, G. (2017) · mAbs · doi:10.1080/19420862.2017.1323159 · Cited by 293
Self-citationHatjiharissi, E., Xu, L., Santos, D. D., Hunter, Z. R., Ciccarelli, B. T., Verselis, S., Modica, M., Cao, Y., Manning, R. J., Leleu, X., et al. (2007) · Blood · doi:10.1182/blood-2007-01-070656 · Cited by 282
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Quast, I., Keller, C. W., Maurer, M. A., Giddens, J. P., Tackenberg, B., Wang, L.-X., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 269
Engineered CHO cells for production of diverse, homogeneous glycoproteins
Yang, Z., Wang, S., Halim, A., Schulz, M. A., Frodin, M., Rahman, S. H., Vester-Christensen, M. B., Behrens, C., Kristensen, C., Vakhrushev, S. Y., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3280 · Cited by 254
Niwa, R., Natsume, A., Uehara, A., Wakitani, M., Iida, S., Uchida, K., Satoh, M., & Shitara, K. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.08.009 · Cited by 244
Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225
In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity
Thomann, M., Schlothauer, T., Dashivets, T., Malik, S., Avenal, C., Bulau, P., Rüger, P., & Reusch, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134949 · Cited by 220 · cited 2×
“Of the FcγRs, we only observed an effect of glycosylation on binding to the FcγRIII-family of receptors, both FcγRIIIa and FcγRIIIb and their allotypes, which confirms and expands recent studies using a limited set of glycovariants presented here (24, 30).”
BackgroundResultA prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C. A. M., Visser, R., Einarsdottir, H. K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A. M., et al. (2014) · Blood · doi:10.1182/blood-2013-09-527978 · Cited by 220
Self-citationMarketing approval of mogamulizumab: A triumph for glyco-engineering
Beck, A., & Reichert, J. M. (2012) · mAbs · doi:10.4161/mabs.20996 · Cited by 211
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Baković, M. P., Selman, M. H. J., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A. M., Lauc, G., & Wuhrer, M. (2013) · Journal of Proteome Research · doi:10.1021/pr300887z · Cited by 204
Self-citationOry, P. A., Clark, M. R., Kwoh, E. E., Clarkson, S. B., & Goldstein, I. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114350 · Cited by 182
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
Subedi, G. P., & Barb, A. W. (2016) · mAbs · doi:10.1080/19420862.2016.1218586 · Cited by 174
Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
Ahmed, A. A., Giddens, J. P., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L., & Björkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 168
Bondt, A., Selman, M. H. J., Deelder, A. M., Hazes, J. M. W., Willemsen, S. P., Wuhrer, M., & Dolhain, R. J. E. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400589m · Cited by 168
Self-citationLópez-Albaitero, A., Lee, S. C., Morgan, S., Grandis, J. R., Gooding, W. E., Ferrone, S., & Ferris, R. L. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0697-4 · Cited by 160
Chen, G., Wang, Y., Qiu, L., Qin, X., Liu, H., Wang, X., Wang, Y., Song, G., Li, F., Guo, Y., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.02.001 · Cited by 150
Forthal, D. N., Gach, J. S., Landucci, G., Jeż, J., Strasser, R., Kunert, R., & Steinkellner, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002600 · Cited by 145
Glycodelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins
Meuris, L., Santens, F., Elson, G., Festjens, N., Boone, M., Dos Santos, A., Devos, S., Rousseau, F., Plets, E., Houthuys, E., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2885 · Cited by 141
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
Dekkers, G., Plomp, R., Koeleman, C. A. M., Visser, R., von Horsten, H. H., Sandig, V., Rispens, T., Wuhrer, M., & Vidarsson, G. (2016) · Scientific Reports · doi:10.1038/srep36964 · Cited by 134
Self-citationKapur, R., Valle, L. D., Sonneveld, M. E., Ederveen, A. L. H., Visser, R., Ligthart, P. C., de Haas, M., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G. (2014) · British Journal of Haematology · doi:10.1111/bjh.12965 · Cited by 132
Self-citationPro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Wuhrer, M., Selman, M. H. J., McDonnell, L. A., Kümpfel, T., Derfuss, T. J., Khademi, M., Olsson, T. P., Hohlfeld, R., Meinl, E., & Krumbholz, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0450-1 · Cited by 132
Self-citationMcGrath, F. D. G., Brouwer, M. C., Arlaud, G. J., Daha, M. R., Hack, C. E., & Roos, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2950 · Cited by 131
Self-citationRegulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet Antigens
Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C. A. M., Deelder, A. M., de Haas, M., & Vidarsson, G. (2008) · Journal of Proteome Research · doi:10.1021/pr800651j · Cited by 130
Self-citationHinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
Plomp, R., Dekkers, G., Rombouts, Y., Visser, R., Koeleman, C. A. M., Lageveen‐Kammeijer, G. S. M., Jansen, B. C., Rispens, T., Hensbergen, P. J., Vidarsson, G., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047381 · Cited by 121
Self-citationSonneveld, M. E., Natunen, S., Sainio, S., Koeleman, C. A. M., Holst, S., Dekkers, G., Koelewijn, J. M., Partanen, J., van der Schoot, C. E., Wuhrer, M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14053 · Cited by 115
Self-citationPhenotypic Variation in IgG Receptors by Nonclassical FCGR2C Alleles
van der Heijden, J., Breunis, W. B., Geissler, J., de Boer, M., van den Berg, T. K., & Kuijpers, T. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003945 · Cited by 110
Self-citationStructural analysis of Fc/FcγR complexes: a blueprint for antibody design
Caaveiro, J. M. M., Kiyoshi, M., & Tsumoto, K. (2015) · Immunological Reviews · doi:10.1111/imr.12365 · Cited by 103
Sibéril, S., de Romeuf, C., Bihoreau, N., Fernandez, N., Meterreau, J.-L., Regenman, A., Nony, E., Gaucher, C., Glacet, A., Jorieux, S., et al. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.10.008 · Cited by 99
C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia
Kapur, R., Heitink‐Pollé, K. M. J., Porcelijn, L., Bentlage, A. E. H., Bruin, M. C. A., Visser, R., Roos, D., Schasfoort, R. B. M., de Haas, M., van der Schoot, C. E., et al. (2014) · Blood · doi:10.1182/blood-2014-05-579110 · Cited by 94
Self-citationBruggeman, C. W., Dekkers, G., Bentlage, A. E. H., Treffers, L. W., Nagelkerke, S. Q., Lissenberg‐Thunnissen, S. N., Koeleman, C. A. M., Wuhrer, M., van den Berg, T. K., Rispens, T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700116 · Cited by 91
Self-citationBranch-Specific Sialylation of IgG-Fc Glycans by ST6Gal-I
Barb, A. W., Brady, E. K., & Prestegard, J. H. (2009) · Biochemistry · doi:10.1021/bi901430h · Cited by 88
Hack, C. E., Paardekooper, J., Smeenk, R. J. T., Abbink, J. J., Eerenberg, A. J. M., & Nuijens, J. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.5.1602 · Cited by 87
Subedi, G. P., Hanson, Q. M., & Barb, A. W. (2014) · Structure · doi:10.1016/j.str.2014.08.002 · Cited by 81
Sonneveld, M. E., Koelewijn, J. M., de Haas, M., Admiraal, J., Plomp, R., Koeleman, C. A. M., Ederveen, A. L. H., Ligthart, P. C., Wuhrer, M., van der Schoot, C. E., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14438 · Cited by 65
Self-citationThabet, M. M., Huizinga, T. W. J., Marques, R. B., Stoeken‐Rijsbergen, G., Bakker, A. M., Kurreeman, F. A. S., White, S. J., Toes, R. E. M., & Mil, A. H. M. V. D. H. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099309 · Cited by 55
Leito, J. T. D., Ligtenberg, A. J. M., van Houdt, M., van den Berg, T. K., & Wouters, D. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.08.010 · Cited by 54
Self-citationImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Le, N. P. L., Bowden, T. A., Struwe, W. B., & Crispin, M. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.016 · Cited by 52
The Majority of Human Memory B Cells Recognizing RhD and Tetanus Resides in IgM+ B Cells
Valle, L. D., Dohmen, S. E., Verhagen, O. J. H. M., Berkowska, M. A., Vidarsson, G., & van der Schoot, C. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400706 · Cited by 39
Self-citationKruijsen, D., Einarsdottir, H., Schijf, M. A., Coenjaerts, F. E. J., van der Schoot, C. E., Vidarsson, G., & van Bleek, G. M. (2013) · Journal of Virology · doi:10.1128/jvi.00493-13 · Cited by 35
Self-citationOboshi, W., Watanabe, T., Matsuyama, Y., Kobara, A., Yukimasa, N., Ueno, I., Aki, K., Tada, T., & Hosoi, E. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.11.001 · Cited by 33
Interpolation method for accurate affinity ranking of arrayed ligand–analyte interactions
Schasfoort, R. B. M., Andree, K., van der Velde, N., van der Kooi, A., Stojanović, I., & Terstappen, L. W. M. M. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.01.023 · Cited by 21
Burkhardt, B., Yavuz, D., Zimmermann, M., Schieferstein, J., Kabíčková, E., Attarbaschi, A., Lisfeld, J., Reiter, A., Makarova, O., Worch, J., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2731-x · Cited by 20
Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
Fokkink, W. R., Falck, D., Santbergen, T. C. M., Huizinga, R., Wuhrer, M., & Jacobs, B. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139828 · Cited by 18
Self-citationPace, D. L., Lewis, N. E., Wu, T. J.-T., Gillespie, R., Dan, L., Velayudhan, J., Rohrbach, A. S., & Connell‐Crowley, L. (2016) · Biotechnology Progress · doi:10.1002/btpr.2300 · Cited by 18
Cited by
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408
Self-citationImmunoglobulin G glycosylation in aging and diseases
Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 408
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Saunders, K. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01296 · Cited by 316
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
Sénard, T., Gargano, A. F. G., Falck, D., de Taeye, S. W., Rispens, T., Vidarsson, G., Wuhrer, M., Somsen, G. W., & Domínguez-Vega, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02049 · Cited by 292
Self-citationHoepel, W., Chen, H.-J., Geyer, C. E., Allahverdiyeva, S., Manz, X. D., de Taeye, S. W., Aman, J., Mes, L., Steenhuis, M., Griffith, G. R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8654 · Cited by 282
Self-citation
Metadata
- Authors
- Dekkers, G., Treffers, L., Plomp, R., Bentlage, A. E. H., de Boer, M., Koeleman, C. A. M., Lissenberg-Thunnissen, S. N., Visser, R., Brouwer, M., Mok, J. Y., Matlung, H., van den Berg, T. K., van Esch, W. J. E., Kuijpers, T. W., Wouters, D., Rispens, T., Wuhrer, M., & Vidarsson, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-02
- Volume
- 8
- Pages
- 877-877
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2741734362
- Cited by
- 356
- References
- 65
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.